Skip to main content

Together we are beating cancer

Donate now

Cancer News

Breast cancer

Breast cancer is the most common cancer in the UK, with around 55,200 people diagnosed each year. It starts in the breast tissue, most commonly in cells lining the milk ducts. Breast cancer predominantly affects women, but men can get it too.
Showing 12 out of 632 results
  • Science & Technology

Tracking down the BRCA2 gene

Our scientists discovered the second breast cancer gene, BRCA2 - we discuss how they made the finding and what this means for cancer patients. Our scientists discovered the second breast cancer gene, BRCA2 - we discuss how they made the finding and what this means for cancer patients.

by Kat Arney | Analysis | 29 February 2012

29 February 2012

This entry is part 10 of 30 in the series Our milestones
  • Science & Technology

Tracking down the BRCA1 gene

We look at our role in the discovery of the famous “cancer gene” BRCA1, responsible for many cases of hereditary breast and other cancers. We look at our role in the discovery of the famous “cancer gene” BRCA1, responsible for many cases of hereditary breast and other cancers.

by Kat Arney | Analysis | 28 February 2012

28 February 2012

This entry is part 9 of 30 in the series Our milestones
Cancer Research UK logo

Leading breast cancer experts are calling for women under 50 diagnosed with triple-negative breast cancer to be offered testing for faults in the BRCA1 gene. Leading breast cancer experts are calling for women under 50 diagnosed with triple-negative breast cancer to be offered testing for faults in the BRCA1 gene.

by Cancer Research UK | News | 15 February 2012

15 February 2012

Cancer Research UK logo

Scientists based at Cancer Research UK's Cambridge Research Institute have discovered how receptors for the female sex hormone oestrogen attach to a different part of the DNA in breast cancer patients who are more likely to relapse, according to a study published in Nature today (Wednesday). Scientists based at Cancer Research UK's Cambridge Research Institute have discovered how receptors for the female sex hormone oestrogen attach to a different part of the DNA in breast cancer patients who are more likely to relapse, according to a study published in Nature today (Wednesday).

by Cancer Research UK | News | 4 January 2012

4 January 2012

Cancer Research UK logo

Italian researchers have shown that the effect of treating women before surgery with trastuzumab (Herceptin) and docetaxel for HER2-positive breast cancer is improved by adding another 'Herceptin-like' drug called pertuzumab. Italian researchers have shown that the effect of treating women before surgery with trastuzumab (Herceptin) and docetaxel for HER2-positive breast cancer is improved by adding another 'Herceptin-like' drug called pertuzumab.

by In collaboration with PA Media Group | News | 7 December 2011

7 December 2011

Cancer Research UK logo

Treatment with lapatinib could extend survival in women with Her2-positive breast cancer that has spread to the brain, according to research published today in the British Journal of Cancer. Treatment with lapatinib could extend survival in women with Her2-positive breast cancer that has spread to the brain, according to research published today in the British Journal of Cancer.

by British Journal of Cancer | News | 30 November 2011

30 November 2011

Cancer Research UK logo

Cancer Research UK has started recruiting patients for a pioneering initiative to demonstrate how genetic tests could be used within the NHS to help match cancer patients to the most appropriate treatment, while building a database of information for research into new targeted therapies. Cancer Research UK has started recruiting patients for a pioneering initiative to demonstrate how genetic tests could be used within the NHS to help match cancer patients to the most appropriate treatment, while building a database of information for research into new targeted therapies.

by Cancer Research UK | News | 21 November 2011

21 November 2011